Short treatment to patients with genotype 2 or 3
Olav Dalgard, Alessandra Mangia – 29 July 2008
Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure
Chia‐Yen Dai, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Yen Hsieh, Ming‐Lung Yu – 29 July 2008
Children with chronic hepatitis C: What future?
Raffaele Iorio, Francesco Cirillo, Vito Terlizzi, Antonietta Giannattasio – 29 July 2008
Which is the best way to analyze the efficacy of albumin dialysis in hepatic encephalopathy?
Rafael Bañares, Agustín Albillos, María‐Vega Catalina – 29 July 2008
Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome
Georgios N. Kalambokis, Epameinondas V. Tsianos – 29 July 2008
Reply:
Véronique Loustaud‐Ratti, Sophie Alain, Annick Rousseau, Pierre Marquet – 29 July 2008
Reply:
Robert J. Fontana – 29 July 2008
Reply:
Peter Ferenci, Ludwig Kramer – 29 July 2008
Reply:
Zachary D. Goodman, Hala R. Makhlouf, Lea Liu, William Balistreri, Regino P. Gonzalez‐Peralta, Barbara Haber, Maureen M. Jonas, Parvathi Mohan, Jean P. Molleston, Karen F. Murray, Michael R. Narkewicz, Philip Rosenthal, Lesley J. Smith, Kathleen B. Schwarz – 29 July 2008
Serum aminotransferase activity and mortality risk
Daniele Prati, Agostino Colli, Laura Porretti – 29 July 2008